Streetbeat News

Earnings

CNK

CRBU

DNUT

FAAS

FRGE

IVVD

KRUS

VTYX

Kura Sushi USA, Inc. (KRUS) shares rose 6% in pre-market trading after announcing Q2 results with sales beating estimates but earnings missing expectations. Other stocks like DigiAsia Corp. (FAAS), Invivyd, Inc. (IVVD), Ventyx Biosciences, Inc. (VTYX), Caribou Biosciences, Inc. (CRBU), Cinemark Holdings, Inc. (CNK), Krispy Kreme, Inc. (DNUT), and Forge Global Holdings, Inc. (FRGE) also saw gains in pre-market trading due to various positive updates and analyst upgrades.

Portfolio Pulse from Avi Kapoor

April 05, 2024 | 12:01 pm

YETI

YETI Holdings (NYSE:YETI) received mixed ratings from 5 analysts, with a shift towards a more cautious stance in the last 30 days. The average 12-month price target is now $41.4, down from $43.00, reflecting a downward revision in expectations. Analyst actions include both downgrades and a single upgrade, with price targets ranging from $36.00 to $48.00. YETI's financial performance remains strong, with significant revenue growth, high net margin, and superior ROE and ROA compared to industry averages.

Portfolio Pulse from Benzinga Insights

April 05, 2024 | 12:01 pm

LIPO

Lipella Pharmaceuticals Inc. (NASDAQ:LIPO) announced its abstract on a new product candidate, LP-50 (intravesical pembrolizumab), for treating non-muscle invasive bladder cancer (NMIBC) has been accepted for the 2024 ASCO meeting. The abstract highlights preclinical data showing efficacy in reducing bladder tumor size in mice with minimal toxicity, leveraging Lipella's liposomal drug delivery technology.

Portfolio Pulse from Benzinga Newsdesk

April 05, 2024 | 12:00 pm

HYMTF

TSLA

Hyundai Motor's North American unit reported a significant year-on-year jump in electric vehicle (EV) sales for Q1 2024, surpassing Ford and General Motors in the US EV market. The sales boost was primarily driven by the Ioniq and Kona models. Hyundai sold 33,522 all-electric vehicles, with the Kona subcompact SUV being the best-seller, starting at $24,250. In comparison, Ford and General Motors sold 20,223 and 16,425 EVs respectively. Tesla's global sales of Model Y and 3 dropped by 11.5%, while Toyota sold 206,850 electrified vehicles in the US.

Portfolio Pulse from Anan Ashraf

April 05, 2024 | 12:00 pm

CRKN

INHD

RPM

The article highlights the top 3 oversold materials stocks that may see significant growth this quarter, based on their low RSI values. Inno Holdings Inc. (INHD) launched a Mobile Factory, RPM International Inc. (RPM) reported Q3 FY24 results with slight sales growth and exceeded EPS expectations, and Crown ElectroKinetics Corp. (CRKN) reported a narrower Q4 loss. All three stocks have seen recent declines but are considered undervalued.

Portfolio Pulse from Avi Kapoor

April 05, 2024 | 11:41 am

QQQ

SPY

Wall Street anticipates a higher opening on Friday, recovering from a previous session sell-off, despite ongoing concerns about potential interest rate hikes. The focus is on the non-farm payrolls report, which could influence market sentiment. Analysts suggest that while strong job data might cause a temporary pullback, a significant rise in average hourly earnings could heighten fears of aggressive rate hikes by the Federal Reserve. The market is also attentive to upcoming Federal Reserve officials' speeches. The CBOE Volatility Index (VIX) indicates increased market volatility. Futures data shows positive movement in major indexes and ETFs like SPY and QQQ in premarket trading. Comments from Fed officials have recently spooked the market, leading to significant losses. Analysts advocate a 'buy-the-dip' strategy, noting key support levels for the S&P 500 and emphasizing the market's sensitivity to inflation and rate hike expectations.

Portfolio Pulse from Shanthi Rexaline

April 05, 2024 | 11:12 am

NTRA

Natera announced results from the Phase 3 IMvigor011 trial in muscle-invasive bladder cancer, showing patients who remained Signatera MRD-negative post-surgery had 100% overall survival at 12 months. The data suggests these patients might avoid adjuvant treatment.

Portfolio Pulse from Benzinga Newsdesk

April 05, 2024 | 11:04 am

AZN

AstraZeneca announced that its drug Imfinzi significantly improved overall survival and progression-free survival in patients with limited-stage small cell lung cancer in the ADRIATIC Phase 3 trial.

Portfolio Pulse from Benzinga Newsdesk

April 05, 2024 | 10:51 am

GLD

SPY

USO

Global markets experienced declines with the U.S. stock markets ending lower due to cautious statements from Federal Reserve officials and anticipation for the U.S. jobs report. The S&P 500 sectors all saw declines, particularly in technology, while defense shares gained. Asian markets also fell, notably Japan's Nikkei 225. European markets and commodities like crude oil and gold saw mixed results. U.S. futures indicated a slight uptick in early trading.

Portfolio Pulse from Akanksha Bakshi

April 05, 2024 | 10:48 am

SHEL

Shell plc (NYSE:SHEL) updated its Q1 FY24 operational outlook, indicating lower LNG trading results but improved production and refinery utilization. Integrated Gas production is expected to be 960-1,000 thousand boe/d, with LNG liquefaction volumes at 7.2-7.6 MT. Upstream production guidance is narrowed to 1,820-1,920 thousand boe/d, with significant exploration write-offs in Albania. Marketing sales volume guidance is slightly reduced, while Chemicals & Products sees increased refinery and chemicals utilization. Q4 FY23 revenue was $78.73 billion, below consensus, but adjusted earnings per ADS exceeded expectations. SHEL shares rose 0.41% in premarket trading.

Portfolio Pulse from Lekha Gupta

April 05, 2024 | 10:45 am